Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandor Kantor

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
The Journal of Pharmacology and Experimental Therapeutics|August 9, 2005
Despite similar anxiolytic potential, the 5-hydroxytryptamine 2C receptor antagonist SB-242084 [6-chloro-5-methyl-1-[2-(2-methylpyrid-3-yloxy)-pyrid-5-yl carbamoyl] indoline] and chlordiazepoxide produced differential effects on electroencephalogram power spectraSandor Kantor, Rita Jakus, Eszter Molnar, et al.
The International Journal of Neuropsychopharmacology|February 12, 2008
Decrease in REM latency and changes in sleep quality parallel serotonergic damage and recovery after MDMA: a longitudinal study over 180 daysEszter Kirilly, Eszter Molnar, Brigitta Balogh, et al.
Brain Research|May 18, 2004
Effect of two noncompetitive AMPA receptor antagonists GYKI 52466 and GYKI 53405 on vigilance, behavior and spike-wave discharges in a genetic rat model of absence epilepsyRita Jakus, Marton Graf, Romeo D Ando, et al.
Behavioural Brain Research|May 5, 2023
Ketamine supresses REM sleep and markedly increases EEG gamma oscillations in the Wistar Kyoto rat model of treatment-resistant depressionSandor Kantor, Michael Lanigan, Lauren Giggins, et al.
Sleep|August 2, 2013
Orexin gene therapy restores the timing and maintenance of wakefulness in narcoleptic miceSandor Kantor, Takatoshi Mochizuki, Stefan N Lops, et al.
Psychopharmacology|April 15, 2004
Effects of a single dose of 3,4-methylenedioxymethamphetamine on circadian patterns, motor activity and sleep in drug-naive rats and rats previously exposed to MDMABrigitta Balogh, Eszter Molnar, Rita Jakus, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
The Journal of Pharmacology and Experimental Therapeutics|August 9, 2005
Despite similar anxiolytic potential, the 5-hydroxytryptamine 2C receptor antagonist SB-242084 [6-chloro-5-methyl-1-[2-(2-methylpyrid-3-yloxy)-pyrid-5-yl carbamoyl] indoline] and chlordiazepoxide produced differential effects on electroencephalogram power spectraSandor Kantor, Rita Jakus, Eszter Molnar, et al.
The International Journal of Neuropsychopharmacology|February 12, 2008
Decrease in REM latency and changes in sleep quality parallel serotonergic damage and recovery after MDMA: a longitudinal study over 180 daysEszter Kirilly, Eszter Molnar, Brigitta Balogh, et al.
Brain Research|May 18, 2004
Effect of two noncompetitive AMPA receptor antagonists GYKI 52466 and GYKI 53405 on vigilance, behavior and spike-wave discharges in a genetic rat model of absence epilepsyRita Jakus, Marton Graf, Romeo D Ando, et al.
Behavioural Brain Research|May 5, 2023
Ketamine supresses REM sleep and markedly increases EEG gamma oscillations in the Wistar Kyoto rat model of treatment-resistant depressionSandor Kantor, Michael Lanigan, Lauren Giggins, et al.
Sleep|August 2, 2013
Orexin gene therapy restores the timing and maintenance of wakefulness in narcoleptic miceSandor Kantor, Takatoshi Mochizuki, Stefan N Lops, et al.
Psychopharmacology|April 15, 2004
Effects of a single dose of 3,4-methylenedioxymethamphetamine on circadian patterns, motor activity and sleep in drug-naive rats and rats previously exposed to MDMABrigitta Balogh, Eszter Molnar, Rita Jakus, et al.
Pageof 2